Evidence map›Paper›PMID 34107578›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].

S P Duan, L H Zhu, L J Hou, H W Wang, X W Zhu, J Hao

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S P DuanDepartment of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
L H ZhuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
L J HouDepartment of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
H W WangDepartment of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
X W ZhuDepartment of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
J HaoMedical Section, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
First Affiliated Hospital of Xinxiang Medical University · CNXinxiang Medical University · CN

Funding

Medical Science and Technique Foundation of Henan Province 201303106
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicAntiviral AgentsCD8-Positive T-LymphocytesDNA, ViralHepatitis B e AntigensHepatitis B virusHumansTenofovirTreatment OutcomeViral LoadAntiviral AgentsDNA, ViralHepatitis B e AntigensTenofovirAntiviralChronic hepatitis BImmune response

Identifiers

PMID34107578
PMCPMC12814271
OpenAlexW3170435123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.